Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 402 results for "ranbaxy industries"

Sun Pharma Gets CCI Nod to Sell Two Ranbaxy Divisions to Strides
NDTV

Sun completes sale of two Ranbaxy divisions to Strides

NEW DELHI: Sun Pharmaceutical Industries today said it has completed the process of selling two divisions of erstwhile Ranbaxy Laboratories to Strides Shasun for Rs 165 crore. All the necessary formalities for closure of the said transaction have been ... Economic Times, 1 week ago
Sun completes sale of 2 Ranbaxy divisions to Strides Business Standard, 1 week ago
[x]  

1 images for "ranbaxy industries"

Money Control, 1 week ago

Sun Pharma Q3 profit seen up 4.4%, Gleevec Halol key

Sun Pharmaceutical Industries ' third quarter profit is seen rising 4.4 percent sequentially to Rs 1,157.71 crore and revenue climbing 1.7 percent to Rs 6,955.44 crore, according to analysts polled by CNBC-TV18. Operating profit (earnings before ...
 Moneycontrol.com16 hours ago
Times of India

Why India is the pharmacy for the world

And that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global price The Hyderabad-based Bharat Biotech might be the first to come out with a vaccine for the Zika virus if ...
 Times of India4 days ago FDA Warns Sun Pharmaceutical of Quality Problems  Peoples Pharmacy1 month ago Sun set in 2015: Issues may haunt Sun Pharma in 2016 too  India Infoline1 month ago US issues new reprimand to Sun Pharma  American Journal of Transportation On-Line1 month ago
[x]  

Mumbai Court rejects union's claim against Sun Pharmaceutical Industries

MUMBAI: The Mumbai Industrial Court has rejected a petition filed by the representatives of workers' union of Sun Pharmaceutical Industries seeking a stay on transfer of dozens of medical representatives who were previously on the rolls of Ranbaxy.
 Economic Times2 days ago Mumbai Court rejects union’s claim against Sun Pharmaceutical Industries  Economic Times2 days ago

1,800 companies legal spend up 18% to $3.5bn - RIL alone billed Rs 1,200 cr, Ranbaxy doubled costs to Rs 850 cr: ET

The Economic Times research arm, the ET Intelligence Group, surveying more than 1,800 listed companies, has revealed that their legal spend was Rs 21,906 crore ($3.5bn) in the 2013-14 financial year, an increase of more than 17.5 per cent on last ...
 Legally India2 days ago

Sun Pharmaceuticals to sell some low priority Ranbaxy brands

MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country's largest drug maker ...
 Economic Times2 weeks ago
Sify

Sensex up over 200 points as buying gains momentum

Thanks to some hectic buying in a few front line stocks, including heavyweights Reliance Industries, Infosys and HDFC, the market has moved up smartly this morning, after a positive but somewhat cautious start. The Sensex is now up 204 points or ...
 Sify1 week ago

Bharti Airtel , Sun Pharma and Firstsource Solutions to see some action today

SENSEX 24559.98 90.41 0.37% NIFTY 7455.45 30.80 0.41% Industries: Banks & Finance, Engineering, Medical/Healthcare, Power, Metal and Mining, Telecom Company Jindal Stainless (Hisar) Ltd , Stone India Ltd , Firstsource ...
 Finalaya.com2 weeks ago
Business Today India

Can Sun Pharma bounce back in 2016?

Six years ago, Dilip Shanghvi, the promoter and Managing Director of Sun Pharmaceutical Industries, was clear and confident when asked two questions that were key to the company's future - Is it risky to over-depend on the US market? And, is it ...
 Business Today India3 weeks ago Sun's Eclipse  Yahoo! India4 weeks ago

Stock gains on divestment of US plant

SINGAPORE --Shares of Sun Pharmaceutical Industries rose on Tuesday in the Indian stock market after the major manufacturer of generic drugs said it will sell off its U.S. plant. The stockedged up0.66% to close at 773.70 rupees ($11.58), having ...
 Nikkei Asian Review1 month ago Sun Pharma stocks rise nearly 2% after its subsidiary divests stake in US unit  DNA1 month ago Sun Pharma shares gain 2% as subsidiary divests US unit  Moneycontrol.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less